Funded Tech Companies
Ceptaris Therapeutics
Headquartered in Malvern, Ceptaris Therapeutics was bought by Actelion.
Company Overview
Company Name
Ceptaris Therapeutics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
101 Lindenwood Dr. 400
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Company Background Information
Overview
Ceptaris Therapeutics Inc., a privately held, specialty pharmaceutical company, is developing a proprietary formulation of mechlorethamine gel for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/1/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Tullman
Chief Medical Officer
Jeffrey Wilkins
Chief Operating Officer
Douglas Gssl
VP - Bus. Development
Evan Dick
VP - General Counsel
Kamil Ali-Jackson
VP - Operations
Jeffrey Shaver
VP - R & D
Timothy Henkel
Company Investors
- Palo Alto Investors (John Doux)
- Vivo Capital (Albert Cha)
- Osage Partners (David Drahms)
- BioAdvance Ventures
- Aperture Venture Partners
- Burrill & Company
- Oxford Finance
- Silicon Valley Bank
- Vivo Capital (James Huang)
- BioAdvance Ventures (Barbara Schilberg)
- TDH Capital Corporation
Browse more funded tech companies:
Cephasonics | Ception Therapeutics
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs